


Ironwood Pharmaceuticals Announces Upcoming Presentation at Wedbush Life Sciences MAC Best Ideas 2010
CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--[ Ironwood Pharmaceuticals, Inc. ] (NASDAQ: IRWD) today announced that Michael Higgins, Ironwooda™s chief financial officer and chief operating officer, will present at Wedbush Life Sciences MAC Best Ideas 2010 on Tuesday, August 3, 2010 at 8:35 a.m. Eastern Time at Le Parker Meridien Hotel in New York.
A live webcast of Ironwooda™s presentation will be accessible through the Investors section of the companya™s website at [ www.ironwoodpharma.com ]. To access the webcast, please log on to the Ironwood website approximately 15 minutes prior to the start of the presentation to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Ironwooda™s website for 14 days following the conference.
About Ironwood Pharmaceuticals
Ironwood Pharmaceuticals (NASDAQ: IRWD) is an entrepreneurial pharmaceutical company dedicated to the art and science of great drugmaking. Linaclotide, Ironwooda™s GCaC agonist, is being evaluated in a confirmatory Phase 3 program for the treatment of irritable bowel syndrome with constipation (IBSaC) and chronic constipation. Ironwood also has a growing pipeline of additional drug candidates in earlier stages of development. Ironwood is located in Cambridge, Mass.
.